Financials in USD. Standardized financial statements.
A compact view of how Solesence, Inc. Common Stock turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue? | $62.06M | $52.35M | $37.30M | $37.32M | $29.48M |
| Revenue Growth? | +18.6% | +40.4% | -0.1% | +26.6% | 0.0% |
| Cost of Revenue? | $46.04M | $36.16M | $29.47M | $28.96M | $20.79M |
| Gross Profit? | $16.03M | $16.19M | $7.83M | $8.36M | $8.69M |
| Gross Margin? | +25.8% | +30.9% | +21.0% | +22.4% | +29.5% |
| Operating Expenses? | $14.46M | $11.06M | $11.37M | $10.62M | $6.13M |
| Operating Income? | $1.57M | $5.13M | -$3.55M | -$2.26M | $2.56M |
| EBITDA? | $2.47M | $6.06M | -$2.80M | -$1.69M | $3.96M |
| Income Before Tax | $1.86M | $4.46M | -$4.38M | -$2.64M | $2.36M |
| Income Tax Expense | $73,000 | $227,000 | $6,000 | -$17,000 | $37,000 |
| Net Income? | $1.79M | $4.24M | -$4.39M | -$2.62M | $2.32M |
| EPS? | $0.03 | $0.07 | $-0.09 | $-0.05 | $0.05 |
| Diluted EPS? | $0.02 | $0.07 | $-0.09 | $-0.05 | $0.05 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality